SORRENTO THERAPEUTICS INC (SRNE)
US83587F2020 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 70.69M | 36.66M | 56.50M | 22.50M | 158.70M | |||
| Marketable Securities | 47.17M | 90.22M | N/A | N/A | 300.00K | |||
| Receivables | 24.19M | 18.71M | 15.50M | 14.50M | 4.40M | |||
| Inventories | 17.96M | 8.11M | 1.80M | 3.40M | N/A | |||
| Other Current Assets | 16.95M | 19.29M | 12.40M | 27.20M | 16.20M | |||
| Total Current Assets | 176.96M | 172.99M | 86.20M | 67.60M | 179.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 128.90M | 126.50M | 73.90M | 76.30M | 24.40M | |||
| Investments And Advances | 55.60M | 51.27M | 256.40M | 262.20M | 265.00M | |||
| Goodwill | 80.20M | 79.53M | 43.60M | 38.30M | 38.30M | |||
| Intangibles | 171.44M | 259.70M | 73.70M | 63.30M | 66.30M | |||
| Other Non-Current Assets | 2.52M | 4.83M | 2.00M | 49.90M | 50.60M | |||
| Total Non-Current Assets | 438.66M | 521.83M | 449.60M | 490.00M | 444.50M | |||
| TOTAL ASSETS | 615.61M | 694.82M | 535.80M | 557.60M | 624.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 52.91M | 31.98M | 23.20M | 36.30M | 10.20M | |||
| Accrued Expenses | 102.33M | 71.02M | 43.70M | 38.00M | 23.60M | |||
| Accounts Payable | 38.39M | 27.41M | 24.70M | 27.60M | 13.80M | |||
| Other Current Liabilities | 8.35M | 9.04M | 4.90M | 13.40M | 14.00M | |||
| Total Current Liabilities | 201.98M | 139.45M | 96.50M | 115.20M | 61.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 17.80M | 110.63M | 92.30M | 199.10M | 223.10M | |||
| Deferred Taxes/Income | 1.74M | 2.43M | 6.90M | 9.00M | 9.40M | |||
| Other Non-Current Liabilities | 263.88M | 364.18M | 199.40M | 201.50M | 122.40M | |||
| Total Non-Current Liabilities | 281.79M | 476.62M | 274.20M | 363.80M | 353.00M | |||
| TOTAL LIABILITIES | 483.77M | 616.07M | 370.70M | 479.00M | 414.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.74B | -1.39B | -958.30M | -659.80M | -367.80M | |||
| Additional Paid In Capital | 1.92B | 1.51B | 1.17B | 788.10M | 626.70M | |||
| Minority Interest | -593.00K | 194.00K | -8.50M | 25.10M | 7.00M | |||
| Common Shares | 47.00K | 32.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -49.46M | -49.46M | -49.50M | -49.50M | -49.50M | |||
| Other Shareholders' Equity | 226.00K | 1.03M | 500.00K | -300.00K | 0.00 | |||
| Shares Outstanding | 460.72M | 307.01M | 267.70M | 160.20M | 122.30M | |||
| Tangible Book Value per Share | -0.26 | -0.85 | 0.18 | -0.14 | 0.86 | |||
| Total Shareholders' Equity | 131.85M | 78.75M | 165.20M | 78.60M | 209.50M | |||
| TOTAL LIABILITIES AND EQUITY | 615.61M | 694.82M | 535.80M | 557.60M | 624.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.14 | 1.40 | 0.56 | 2.53 | 1.06 | |||
| Current Ratio | 0.88 | 1.24 | 0.89 | 0.59 | 2.92 | |||
| Return On Assets (ROA) | -80.17% | -61.65% | -55.71% | -52.39% | -32.61% | |||
| Return On Equity (ROE) | -374.35% | -543.92% | -180.69% | -371.63% | -97.14% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD